ADVERTISEMENT
News
ADHD Stimulant Recalled
02/24/2020
The recall affects the following products, which were distributed throughout the United States:
- methylphenidate hydrochloride extended-release tablets, 18 mg, 100-count bottles (NDC 62037-725-01) from lot 1332796 A (Exp. 11/20), and
- methylphenidate hydrochloride extended-release tablets, 27 mg, 100-count bottles (NDC 62037-734-01) from lot 1332799A (Exp. 11/20).
Teva Pharmaceuticals voluntarily initiated the recall January 27, 2020. The FDA designated the recall Class II on February 10, 2020. Use of a drug under a Class II recall could cause temporary or medically reversible adverse health consequences, or a remote possibility of serious harm.
Methylphenidate is a prescription stimulant used to treat attention-deficit/hyperactivity disorder as well as narcolepsy.
—Jolynn Tumolo